 SAN DIEGO, March 16, 2022 GLOBE NEWSWIRE -- Progenity, Inc. Nasdaq: PROG, a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2021 on Monday, March 28, 2022 after the close of financial markets. Progenitys management will host a webcast and conference call at 4:30 p.m. Eastern 1:30 p.m. Pacific that day to discuss the financial results and provide a corporate update. 